Promoting Natural Painkiller
- Author: David Bradley
- Published: 23 September 2010
- Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
- Source / Publisher: Nature Neuroscience/Nature Publishing Group
Related Articles
Researchers in Italy and the US lead by Daniele Piomelli, University of California Irvine, have developed a new compound, URB937, that stimulates endogenous anandamide, a natural form of tetrahydrocannabinol (THC) known as the "bliss molecule". URB937 inhibits the breakdown of anandamide by the enzyme fatty acid amide hydrolase (FAAH). Blocking FAAH activity enhances the effects of anandamide without generating the "high" seen with THC itself and could enable medical marijuana use.
This or a related compound might one day form the basis of potent pain relief that avoids the sedative and addiction side effects commonly seen with opiate painkillers such as morphine and diamorphine.
- Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
J. R Clapper, G. Moreno-Sanz, R. Russo, A. Guijarro, F. Vacondio et al.,
Nature Neurosci. 2010, 13.
DOI: 10.1038/nn.2632
Article Views: 2225
Sign in Area
Additional Sign In options
Article Comments - To add a comment please sign in
Most Read
-
Society:
ChemPubSoc Europe
-
Education:
Why Does Iodine Turn Starch Blue?
-
Magazine:
Georg Michael Hanack (1931 – 2019)
-
Education:
What are Fluorescence and Phosphorescenc...
-
Magazine:
The Most Efficient Way to Find pKa Value...
If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more
|
|
|
 |
 |
 |
 |
 |
A product of 
and Wiley-VCH
Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.